An operating lease is treated like a rental contract. Neither the leased asset nor the associated liability is reported on the lessee balance sheet, but the rights may be very similar to the rights of an owner. The lessee only records the lease payments as a rental expense in income statement.

Adjustments to Financial Statements for Operating Leases
Adjusted Financial Ratios for Operating Leases (Summary)
Adjusted Total Asset Turnover
Adjusted Debt to Equity
Adjusted Return on Assets (ROA)

Edwards Lifesciences Corp., adjustments to financial statements

US$ in thousands

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Adjustment to Total Assets
Total assets (as reported)	8,502,600)	7,237,100)	6,488,100)	5,323,700)	5,695,800)
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)¹	—)	—)	—)	82,604)	67,539)
Total assets (adjusted)	8,502,600)	7,237,100)	6,488,100)	5,406,304)	5,763,339)
Adjustment to Total Debt
Total debt (as reported)	595,700)	595,000)	594,400)	593,800)	1,036,400)
Add: Operating lease liability (before adoption of FASB Topic 842)²	—)	—)	—)	82,604)	67,539)
Add: Operating lease liabilities, current portion	25,500)	27,200)	25,500)	—)	—)
Add: Operating lease liabilities, long-term portion	69,100)	72,700)	58,900)	—)	—)
Total debt (adjusted)	690,300)	694,900)	678,800)	676,404)	1,103,939)

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

^{1, 2} Equal to total present value of future operating lease payments.

Edwards Lifesciences Corp., Financial Data: Reported vs. Adjusted

Download chart

Edwards Lifesciences Corp., adjusted financial ratios

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Total Asset Turnover¹
Reported total asset turnover	0.62	0.61	0.67	0.70	0.60
Adjusted total asset turnover	0.62	0.61	0.67	0.69	0.60
Debt to Equity²
Reported debt to equity	0.10	0.13	0.14	0.19	0.35
Adjusted debt to equity	0.12	0.15	0.16	0.22	0.37
Return on Assets³ (ROA)
Reported ROA	17.68%	11.38%	16.14%	13.57%	10.25%
Adjusted ROA	17.68%	11.38%	16.14%	13.36%	10.13%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

¹ See details »

² See details »

³ See details »

Financial ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	Edwards Lifesciences Corp. adjusted total asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021.
Adjusted debt to equity	A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity.	Edwards Lifesciences Corp. adjusted debt to equity ratio improved from 2019 to 2020 and from 2020 to 2021.
Adjusted ROA	A profitability ratio calculated as net income divided by adjusted total assets.	Edwards Lifesciences Corp. adjusted ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Edwards Lifesciences Corp., Financial Ratios: Reported vs. Adjusted

Download chart

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net sales	5,232,500)	4,386,300)	4,348,000)	3,722,800)	3,435,300)
Total assets	8,502,600)	7,237,100)	6,488,100)	5,323,700)	5,695,800)
Activity Ratio
Total asset turnover¹	0.62	0.61	0.67	0.70	0.60
Adjusted for Operating Leases
Selected Financial Data (US$ in thousands)
Net sales	5,232,500)	4,386,300)	4,348,000)	3,722,800)	3,435,300)
Adjusted total assets	8,502,600)	7,237,100)	6,488,100)	5,406,304)	5,763,339)
Activity Ratio
Adjusted total asset turnover²	0.62	0.61	0.67	0.69	0.60

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

¹ Total asset turnover = Net sales ÷ Total assets
= 5,232,500 ÷ 8,502,600 = 0.62

² Adjusted total asset turnover = Net sales ÷ Adjusted total assets
= 5,232,500 ÷ 8,502,600 = 0.62

Download chart

Activity ratio	Description	The company
Adjusted total asset turnover	An activity ratio calculated as total revenue divided by adjusted total assets.	Edwards Lifesciences Corp. adjusted total asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021.

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Total debt	595,700)	595,000)	594,400)	593,800)	1,036,400)
Stockholders’ equity	5,835,900)	4,574,300)	4,148,300)	3,140,400)	2,956,200)
Solvency Ratio
Debt to equity¹	0.10	0.13	0.14	0.19	0.35
Adjusted for Operating Leases
Selected Financial Data (US$ in thousands)
Adjusted total debt	690,300)	694,900)	678,800)	676,404)	1,103,939)
Stockholders’ equity	5,835,900)	4,574,300)	4,148,300)	3,140,400)	2,956,200)
Solvency Ratio
Adjusted debt to equity²	0.12	0.15	0.16	0.22	0.37

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

¹ Debt to equity = Total debt ÷ Stockholders’ equity
= 595,700 ÷ 5,835,900 = 0.10

² Adjusted debt to equity = Adjusted total debt ÷ Stockholders’ equity
= 690,300 ÷ 5,835,900 = 0.12

Download chart

Solvency ratio	Description	The company
Adjusted debt-to-equity	A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity.	Edwards Lifesciences Corp. adjusted debt-to-equity ratio improved from 2019 to 2020 and from 2020 to 2021.

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income	1,503,100)	823,400)	1,046,900)	722,200)	583,600)
Total assets	8,502,600)	7,237,100)	6,488,100)	5,323,700)	5,695,800)
Profitability Ratio
ROA¹	17.68%	11.38%	16.14%	13.57%	10.25%
Adjusted for Operating Leases
Selected Financial Data (US$ in thousands)
Net income	1,503,100)	823,400)	1,046,900)	722,200)	583,600)
Adjusted total assets	8,502,600)	7,237,100)	6,488,100)	5,406,304)	5,763,339)
Profitability Ratio
Adjusted ROA²	17.68%	11.38%	16.14%	13.36%	10.13%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

2021 Calculations

¹ ROA = 100 × Net income ÷ Total assets
= 100 × 1,503,100 ÷ 8,502,600 = 17.68%

² Adjusted ROA = 100 × Net income ÷ Adjusted total assets
= 100 × 1,503,100 ÷ 8,502,600 = 17.68%

Download chart

Profitability ratio	Description	The company
Adjusted ROA	A profitability ratio calculated as net income divided by adjusted total assets.	Edwards Lifesciences Corp. adjusted ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level.

Edwards Lifesciences Corp. (NYSE:EW)

Analysis of Operating Leases

Adjustments to Financial Statements for Operating Leases

Edwards Lifesciences Corp., Financial Data: Reported vs. Adjusted

Adjusted Financial Ratios for Operating Leases (Summary)

Edwards Lifesciences Corp., Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Adjusted Debt to Equity

Adjusted Return on Assets (ROA)